JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.23, no.3, pp.485-488, 2004 (SCI-Expanded)
The aim of this study was to investigate serum levels of IL-2, IL-6 and IL-10 in the pretreatment period and to determine if high IL-2, IL-6, IL-10 levels correlate with the outcome in patients with Non-Hodgkin's Lymphoma (NHL) in the post treatment period.